Patrick Trucchio Stock Analyst Profile - HC Wainwright & Co. Research Coverage - Stocknear

Patrick Trucchio

Stock Analyst at HC Wainwright & Co.

(4.2)
# 1777
Out of 5,506 analysts
435
Total ratings
Success rate
Average return

39 Stocks

Name Action PT Current % Upside Ratings Updated
ASMB Assembly Biosciences
Assumes: Buy
50
23.32 114.41% 1 Aug 18, 2025
ALT Altimmune
Reiterates: Buy
12 12
3.91 206.91% 19 Aug 13, 2025
ALNY Alnylam Pharmaceutic...
Maintains: Strong Buy
500 570
456.35 24.9% 27 Aug 7, 2025
CMPS Compass Pathways
Maintains: Buy
45 40
6.43 522.08% 17 Aug 4, 2025
ATAI ATAI Life Sciences
Maintains: Strong Buy
10 15
5.23 186.81% 20 Jul 30, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
10 10
6.9 44.93% 2 Jun 26, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
5 5
1.16 331.03% 19 Jun 26, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
10 10
0.68 1370.59% 26 Jun 24, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
75 75
5 1400% 24 Jun 13, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
100 100
34.21 192.31% 21 Jun 2, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
70 70
54.92 27.46% 15 May 29, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
5 5
1.38 262.32% 18 May 21, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
60 60
5.44 1002.94% 18 May 21, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
80 80
36.12 121.48% 23 May 20, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
40 40
13.1 205.34% 15 May 9, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
30 30
4.86 517.28% 10 Apr 8, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
70 70
27.28 156.6% 6 Apr 8, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
80 80
25.75 210.68% 8 Apr 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
25 10
2.11 373.93% 19 Apr 1, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
10 10
2.57 289.11% 16 Mar 18, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
55 55
12.56 337.9% 18 Mar 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
110 110
5.73 1819.72% 23 Feb 28, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
85 85
53.26 59.59% 2 Feb 19, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
190 150
6.07 2371.17% 17 Feb 13, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
80 60
n/a n/a 14 Oct 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
15 7
n/a n/a 8 Nov 28, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
360
n/a n/a 5 May 15, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
5
n/a n/a 2 Mar 23, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
20
n/a n/a 1 Feb 15, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
3
n/a n/a 2 Feb 7, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
5
n/a n/a 1 Oct 3, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
170 68
13.84 391.33% 2 Sep 23, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
35 7
n/a n/a 4 Jul 15, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
120 100
n/a n/a 3 Feb 9, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
230 20
n/a n/a 2 Dec 28, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
500 625
n/a n/a 2 Nov 22, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
25 10
n/a n/a 3 Oct 19, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
260 340
183.57 85.22% 1 Aug 18, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
8
n/a n/a 1 Jul 26, 2021